Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. 

Biotechnology

Arch Therapeutics

Terrence W. Norchi

Shawn Carlson

Chirag B. Shah

Richard E. Davis

Michael Abrams

The Leadership Team at Arch Therapeutics is responsible for guiding the strategic direction and operational oversight of the company. This team, comprised of key executives such as the CEO, CFO, and VPs of R&D and Engineering, collaborates to drive innovation in biotechnology, ensure financial stability, and foster a culture of excellence in the development of advanced hemostatic and sealing solutions for surgical and trauma care.

Leadership Team

About

Team members

Other teams at Arch Therapeutics

Advisory Team